morning welcome scientific first quarter conference call name coordinate call today operator instruction would like introduce moderator call vice president investor relation begin call vice president investor relation good morning thank join call today chairman president chief executive officer senior vice president chief financial officer please note call webcast live archive investor section website thermofisher head news event copy press release first quarter earn available investor section website head financials begin briefly cover safe harbor statement various remark make company future expectation plan prospect constitute forward look statement purpose safe harbor provision private security litigation reform actual result differ materially indicate forward look statement result various important factor include discuss company recent annual report form file available investor section website head financials file elect update forward look statement point future specifically disclaim obligation even estimate change therefore rely forward look statement represent view date subsequent today also call refer certain financial measure prepare accordance generally accept account principle reconciliation financial measure directly comparable measure available press release first quarter full year earn also investor section website head financials turn call chairman president chief executive officer thank good morning everyone thank join today first quarter call press release strong start year deliver another quarter excellent financial performance core business perform strength broad base include clinical research business integration smoothly even excite opportunity enable success pharma biotech customer reflect quarter please great execution share gain across business continue success result prove growth strategy business system continue differentiator enable strengthen company find better every think macro event much change since start year rise inflation lockdown change ability navigate dynamic landscape deliver exceptional performance first quarter result outlook year recap financials revenue quarter grow year year billion adjust operate income billion adjust operate margin first quarter deliver another quarter strong adjust performance achieve share give color performance market build momentum deliver excellent performance start year outstanding result quarter strong execution good market condition share gain also meaningful contribution test continue support customer need start pharma biotech another outstanding quarter performance deliver growth teen broad base strength market customer value trust partner status academic government grow single digit quarter good growth bioscience electron microscopy research safety market channel turn industrial apply grow teen quarter strong growth analytical instrument business electron microscopy chromatography mass spectrometry chemical analysis research safety market channel finally diagnostics healthcare revenue decline teen core business strong growth clinical diagnostics transplant diagnostics healthcare market channel quarter execute really support test need provide update progress make execute prove growth strategy consist three element commitment high impact innovation scale high growth emerge market unique value proposition customer make great progress first quarter share highlight start first pillar fantastic quarter high impact innovation launch number product help customer break important work highlight genetic science business launch apply flex series genetic analyzer improve clinical research advance scientific discovery analytical instrument launch four chromatography instrument advance analytical test food environmental industrial pharmaceutical application include scientific trace series incorporate enhance automation instrument health monitor offer flexibility customer optimize workflow bioproduction launch system efficient delivery genetic material cell part cell therapy manufacture addition sign agreement precision diagnostic company develop assay system improve cancer tumor profile advance precision medicine small sample outstanding innovation across company enable customer success strengthen position world leader serve science second pillar growth strategy leverage scale high growth emerge market create differentiate experience customer strong performance market include grow double digit quarter analytical instrument business around world advance scientific research include high growth emerge market example national institute biological science mass spectrometer accelerate research structural biology electron microscope enable national university establish center accelerate virus research turn third pillar growth strategy unique customer value proposition continue enhance capability even stronger partner industry leader help customer advance cell gene therapy open facility provide biological sample storage cell therapy logistics bioproduction network expansion quarter bring additional capacity online single bioprocess container cell culture medium reflect trust partner status pharma biotech customer enter year strategic collaboration agreement establish large scale manufacture base vaccine therapy agreement provide dedicate capacity range aseptic fill finish service along inspection label final package quarter chance visit north campus invest significantly past couple year expand capacity capability build support pipeline truly impressive turn capital deployment like share step take strengthen customer value proposition build future continue successfully execute discipline capital deployment strategy combination strategic return capital shareholder give first full quarter contribution clinical research business like update progress business perform ahead deal model strong start outlook year allow increase expectation business cover detail remark term integration smoothly customer value combination realize first commercial synergy secure authorization pharma biotech customer value combination capability bode long term revenue synergy fuel growth support increase demand biopharma customer also invest expand clinical research operation finally super impress visit different site together take business next level part become even stronger partner customer mention last call close lead provider bioscience reagent late last year please note business great start integration incredibly complete small bolt deal analytical instrument enhance material structural analysis offer customer quarter also return significant capital shareholder repurchase billion share increase dividend turn brief update initiative mark significant milestone first quarter exceed million readily recyclable paper cooler ship transport cold chain product without traditional foam cooler build commitment environmental stewardship enable broad adoption sustainable solution addition recently announce partnership university advance innovation sustainability talent development year partnership establish network technology center focus accelerate collaborative research advance innovation range scientific field also accelerate educational opportunity especially resourced student engage joint stem community outreach program support curriculum development scholarship fellowship career mentor recruitment cover guidance like comment reflection event impact colleague world large always priority health safety colleague support colleague displace variety need together colleague globally make substantial donation relief organization respond enable safe country many colleague face lengthy lockdown disruption daily life pandemic provide care package resident face limit food supply also recognize inflation challenge provide special payment summer colleague like review guidance high level take detail meaningfully raise full year guidance increase revenue guidance million billion would result report revenue growth raise adjust guidance share guidance factor excellent include strong core business outlook remainder year incorporate expect impact recent macroeconomic dynamic result increase guide year reflect navigate dynamic time summarize takeaway first quarter outstanding result drive prove growth strategy business system business perform gain market share acquisition generate strong return really position continue differentiate stakeholder enable raise outlook solidify incredibly bright future hand call senior vice president chief financial officer thank good morning everyone press release start year excellent quarter deliver core organic growth billion test revenue adjust earn share billion free cash flow revenue billion higher incorporate previous guidance million drive strong start year core business million test strength core broad base across business market geography business system enable generate strong pull revenue adjust higher include previous guidance broad base beat start year provide detail performance begin earn result mention deliver adjust versus prior year quarter versus prior year topline report revenue grow year year component report revenue increase include organic revenue growth contribution acquisition headwind foreign exchange core organic revenue growth quarter mention deliver billion test revenue turn organic revenue performance geography organic growth rate region skew test revenue current prior year north grow single digit flat pacific grow teen grow double digit rest world decline single digit respect operational performance adjust operate income quarter decrease adjust operate margin basis point lower last year adjust operate margin come slightly higher anticipate prior guidance reflect growth strategy business system enable manage dynamic time execute strong price realization productivity volume leverage core business enable appropriately address higher inflation offset expect impact incorporate financials lower test volume impact strategic investment include continue investment colleague move detail total company adjust gross margin quarter come basis point lower last year first quarter change gross margin driver adjust operate margin adjust quarter revenue decrease basis point versus total expense approximately million represent growth prior year reflect ongoing investment high impact innovation fuel future growth look result line quarter interest expense million million higher last year largely acquisition finance activity adjust rate quarter basis point lower last year drive plan initiative average dilute share million approximately million lower year year drive share repurchase option dilution turn cash flow balance sheet cash flow another strong highlight quarter business system enable deliver significant cash flow strong topline performance cash flow operate activity billion free cash flow quarter billion capacity capability investment progress quarter capital expenditure million return billion capital shareholder buyback also quarter increase dividend approximately billion cash billion total debt leverage ratio quarter time gross debt adjust time debt basis conclude comment total company performance adjust reflect strong return investment generate across company provide color performance four business segment start couple frame comment scale margin profile test revenue vary segment test revenue significantly higher prior year quarter skew report segment margin previously mention refer acquire business clinical research business reside laboratory product biopharma service segment move segment detail start life science solution report revenue segment increase organic revenue lower prior year quarter deliver strong growth bioproduction bioscience business offset lower revenue genetic science business drive lower test revenue versus year quarter adjust operate income life science solution decrease adjust operate margin basis point year year quarter deliver strong productivity offset business strategic investment analytical instrument segment report revenue increase organic growth strong growth segment quarter lead electron microscopy chromatography mass spectrometry business adjust operate income segment increase adjust operate margin basis point year year quarter deliver strong volume pull productivity offset strategic investment make across segment turn specialty diagnostics report revenue decline organic revenue decline quarter strong underlie growth healthcare market channel transplant diagnostics clinical diagnostics business offset lower test revenue versus year quarter adjust operate income decrease quarter adjust operate margin basis point prior year drive strong productivity offset business strategic investment segment finally laboratory product biopharma service segment report revenue segment increase organic growth strong growth research safety market channel laboratory product business clinical research business perform quarter grow point company average core organic growth rate contribute billion revenue segment quarter adjust operate income segment decrease increase adjust operate margin basis point lower prior year quarter drive strong productivity offset strategic investment business turn update guidance outline raise full year revenue guidance million billion also raise core organic revenue growth outlook year bottom line increase adjust guidance year strong outlook particularly also factor notable macro development occur follow last earn call continue excellent navigate fluid macroeconomic environment help deliver outstanding result reflect strength prove growth strategy power business system operate speed scale detail guidance raise term revenue three element drive raise guidance million higher assume test revenue year million decrease change rate million increase outlook core business core revenue raise incorporate million headwind conflict lockdown choose derisk million vaccine therapy revenue outlook offset core revenue guidance assume billion vaccine therapy revenue total incorporate still able raise full year outlook core show business perform mention previously increase core organic growth outlook year term test revenue assumption continue derisked approach guidance range outcome year guidance assume billion test revenue represent billion deliver million assume endemic rate level million revenue quarter second half year scenario test demand could higher level case position support customer need flow benefit think prudent continue take derisked approach outlook term profitability expect deliver million adjust operate income million raise revenue guidance reflect strong pull additional revenue partially offset million additional compensation colleague help temporary impact inflation continue expect adjust operate margin term adjust stronger business outlook enable raise adjust guidance build already strong outlook year provide couple detail guidance help model clinical research business expect deliver billion revenue represent core organic growth full year basis business three percentage point previous guidance expect business deliver billion adjust operate income contribute adjust year prior guidance expect year year headwind million revenue adjust continue expect interest expense approximately million year expect adjust income rate slightly higher prior guide drive improve earn outlook continue assume capital expenditure approximately billion billion free cash flow approximately billion guidance still assume billion capital deployment billion share buyback complete million capital return shareholder dividend estimate full year average dilute share count million million share finally couple comment phase help model revenue dollar remainder year expect fairly linear slightly higher core organic growth expect lower estimate basis point impact lockdown term adjust phase expect percentage full year slightly lower comparable period last year conclude deliver excellent start year great position achieve goal turn call back vice president investor relation thank operator ready take question